Table 3.

Maternal and Perinatal Complications Stratified by GA at Inclusion With sFlt‐1/PlGF >655

GA et Inclusion, wks	No. of Cases	Maternal Morbidity	Neonatal Severe Adverse Outcome
			Any	Intrauterine Demise	Neonatal Demisea	Severe Morbidityb
≤24	29	13 (44.8)	26 (89.7)	12 (41.3)	6 (26.1)	8 (72.7)
25–26	38	23 (60.5)	31 (81.6)	7 (18.4)	7 (22.5)	17 (70.8)
27–28	51	20 (39.2)	33 (64.7)	1 (2.0)	2 (0.4)	30 (62.5)
29–30	50	24 (48.0)	10 (20.0)	0 (0)	0 (0)	10 (38.5)
31–32	42	14 (33.3)	7 (16.6)	1 (2.4)	0 (0)	6 (14.6)
33–34	17	6 (35.3)	3 (17.6)	0 (0)	0 (0)	3 (17.6)
35–37	10	3 (30.0)	0 (0)	0 (0)	0 (0)	0 (0)

^aGA, gestational age; PlGF, placental growth factor; and sFlt‐1, soluble fms‐like tyrosine kinase 1.Among liveborn children.

^bAmong perinatal survivors.